Frequently Asked Questions

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a minimally invasive procedure involving the delivery of chemotherapy as an aerosol. It offers a targeted approach to treating peritoneal surface malignancies with fewer side effects.  

Cytoreductive Surgery involves removing visible tumors in the peritoneal cavity, followed by HIPEC, where heated chemotherapy is circulated in the abdomen to destroy any remaining cancer cells. This combined approach aims to improve treatment efficacy.  

Peritoneal Surface Malignancies can arise from various primary cancers, including those originating in the appendix, rectum, colon, stomach, ovaries, and other organs. AIIO's expertise covers a spectrum of these cancers.

AIIO specializes in groundbreaking treatments like Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). These procedures aim to transform palliative conditions into curative outcomes.  

AIIO has earned recognition as a Center of Excellence due to its expertise in treating peritoneal surface malignancies. The certification highlights our commitment to delivering advanced and comprehensive care for these challenging cancers.  

Peritoneal Surface Malignancy refers to cancers that develop on the lining of the abdomen, known as the peritoneum. These cancers often originate from tumors in various organs like the appendix, rectum, colon, stomach, ovaries, or others, spreading to peritoneal surfaces.  

For more information about robotic surgery options at Aster International Institute of Oncology, you can schedule a consultation with our expert surgical oncologists. Contact our hospital for personalized guidance and to address any specific queries you may have.  

Robotic surgery may not be suitable for every patient or every type of cancer. The decision to use robotic technology is made based on factors such as the type and stage of cancer, the patient's overall health, and the surgeon's assessment.  

Patients undergoing robotic oncology surgeries often experience shorter recovery periods compared to traditional surgery. The exact duration varies depending on the type of procedure and individual patient factors. The medical team provides personalized post-operative care guidelines.  

While robotic surgery is generally considered safe, as with any medical procedure, there are inherent risks. These may include infection, bleeding, or reactions to anesthesia. The surgical team at AIIO assesses individual patient factors to minimize these risks.